Biotech and Pharmaceuticals Pharmaceuticals

More

  • Cramer works the crowd during his "Mad Money: It's a Family Affair" special.

    Cramer, ever the contrarian, disagrees with that sentiment. He prefers his stocks at a different temperature.

  • Healthcare stocks rebound, so is significant reform dead? Healthcare stocks have been moving off their lows since Tuesday and are up significantly today after moving almost straight down in June.

  • Two days after the FDA ordered Matrixx Initiatives' Zicam off the market the story remains one of the most emailed articles on "The New York Times" website. And the company seems to still be trying to find its corporate crisis footing.

  • Wondering what happened to the rally? Cramer puts stocks’ sudden declines into perspective.

  • Zicam

    I was an early adopter of Zicam when it came on the market 10 years ago. Whenever I felt a cold coming on, I'd load up on the stuff along with Vitamin C and zinc lozenges. So, last night I went searching through the bathroom cabinets to find my Zicam stash to toss it in the trash per the FDA's advisory.

  • While the charts say one thing, Cramer thinks something entirely different.

  • Doctor examines a man at a public health center set up to check for swine flu symptoms

    Concerned over the surge of phony swine flu treatments hawked on the Internet, the Food and Drug Administration has ordered dozens of Web site operators to stop making fraudulent claims, leading to a drop in the number of scams.

  • Lipitor

    I have a confession to make. I try to be as transparent as possible, to share as much information as I can about how the sausage is made. To that end, on at least a few occasions I’ve mentioned on this blog and on CNBC, that I’ve been on 10 milligrams of Lipitor.

  • The Dow eked out a gain Friday, bumping it into positive territory for the year, as Bank of America shares  rallied. But techs, energy and commodities retreated as crude oil dropped to around $72 a barrel.

  • Stocks opened lower Friday as crude oil dropped below $71 a barrel and banks dragged after Bank of America lowered its outlook for the sector.

  • genentech_slide34.jpg

    This morning the apparently Red Bull-fueled (or maybe he's a Starbucks triple-shot guy) biotech analyst at Deutsche Bank, Dr. Mark Schoenebaum, did a deep dive for clients in a presentation he called, "Getting ready for summer!"

  • Stocks opened lower Friday as crude oil dropped below $71 a barrel and banks dragged after Bank of America lowered its outlook for the sector.

  • Futures pointed to a negative open for Wall Street Friday as crude oil dropped below $71 a barrel and banks dragged after Bank of America lowered its outlook for the sector.

  • Pharma Stocks

    To almost no one's surprise, for the first time in 41 years, the World Health Organization has declared a full-blown swine flu pandemic. But the declaration is tied more to the geographic spread of the virus than it is to its virulence.

  • Dr. Mark Monane, senior biotech analyst at Needham & Co., named some biotech stocks that look attractive.

  • Shares of Lilly are off about 6% over the past month – down much more than the overall healthcare sector. Why can’t Lilly get any love?

  • Medtronic spokesman Steve Cragle sent CNBC this clarification to Mr. Hawkins' answer to Mike Huckman's question regarding the Senate investigation into a doctor who has done consulting work for MDT.

  • The judge threw the book at the man, but at the same time he didn't sentence him by the book. Andrew Bodnar pleaded guilty to his role in the generic Plavix brouhaha a couple of years ago. And yesterday a District Court judge fined him $5,000 and ordered Bodnar to write a book about what happened. Write a book!

  • graphic_fast_money.jpg

    For people struggling with diabetes, the bathroom scale can be the enemy. But new developments may change that and more!

  • Risky Business

    "It's a risky business." I don't think I'll ever forget when a Chief Financial Officer said that at an investor conference last year in lieu of reading the whole boring boilerplate "Safe Harbor Statement."